Pediatric Non-Hodgkin Lymphoma: A Retrospective 14-Year Experience with Berlin-Frankfurt-Münster (BFM) Protocols from a Tertiary Care Hospital in Serbia

REFERENCES

• Atra A, Imeson JD, Hobson R, Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol. Br J Cancer. 2000;82:1396–1402.
   PubMed Web of Science ®Google Scholar
• Burkhardt B, Zimmermann M, Oschlies I, The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol. 2005;131:39–49.
   PubMed Web of Science ®Google Scholar
• Cairo MS, Krailo MD, Morse M, Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate (‘Orange’) in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report. Leukemia. 2002;16:594–600.
   PubMed Web of Science ®Google Scholar
• Eden OB, Hann I, Imeson J, Treatment of advanced stage T cell lymphoblastic lymphoma: results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503. Br J Haematol. 1992;82:310–316.
   PubMed Web of Science ®Google Scholar
• Le Deley MC, Rosolen A, Williams DM, Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial. J Clin Oncol. 2010;28:3987–3993.
   PubMed Web of Science ®Google Scholar
• Marky I, Bjork O, Forestier E, Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the Nordic Society of Pediatric Hematology and Oncology. J Pediatr Hematol Oncol. 2004;26:555–560.
   PubMed Web of Science ®Google Scholar
• Patte C, Auperin A, Gerrard M, Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood. 2007;109:2773–2780.
   PubMed Web of Science ®Google Scholar
• Reiter A, Schrappe M, Parwaresch R, Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage—a report of the Berlin-Frankfurt-Münster Group. J Clin Oncol. 1995;13:359–372.
   PubMed Web of Science ®Google Scholar
• World Health Organization Classification of Tumors. In: Harris NL, Jaffe ES, Vardiman JW, Stein H, Diebold J, Müller-Hermelink HK, Flandrin G. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001:10–14.
   Google Scholar
• Reiter A. Diagnosis and treatment of childhood non-hodgkin lymphoma. Hematology Am Soc Hematol Educ Program. 2007:285–296.
   PubMedGoogle Scholar
• Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Semin Oncol. 1980;7:332–339.
   PubMed Web of Science ®Google Scholar
• Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004;127:3–11.
   PubMed Web of Science ®Google Scholar
• Pession A, Masetti R, Rondelli R. Pediatric T-cell acute lymphoblastic leukemiaand T-cell lymphoblastic lymphoma therapy. Hematol Meet Rep. 2009;3:111–114.
   Google Scholar
• Seidemann K, Tiemann M, Lauterbach I, Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group. J Clin Oncol. 2003;21:1782–1789.
   PubMed Web of Science ®Google Scholar
• Dokmanovic L, Janic D, Jovanovic N, Ivanovski P. Treatment results for B cell lymphoma and leukemia using BFM protokols with reduced MTX to 2g/m2: a single institution experience. Pediatr Blood Cancer. 2004;43:434.
   Google Scholar
• Percy CL, Smith MA, Linet M, Lymphomas and reticuloendothelial neoplasms. In: Ries LAG, Smith MA, Gurney JG, , eds. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995. Bethesda: National Cancer Institute, SEER Program; 1999:35–50. NIH Publication No. 99-4649.
   Google Scholar
• Baez F, Pillon M, Manfredini L, Treatment of pediatric non-Hodgkin lymphomas in a country with limited resources: results of the first national protocol in Nicaragua. Pediatr Blood Cancer. 2008;50:148–152.
   PubMed Web of Science ®Google Scholar
• Fadoo Z, Belgaumi A, Alam M, Pediatric lymphoma: a 10-year experience at a tertiary care hospital in Pakistan. J Pediatr Hematol Oncol. 2010;32:e14–e18.
   PubMedGoogle Scholar
• Moleti ML, Al-Hadad SA, Al-Jadiry MF, Treatment of children with B-cell non-Hodgkin lymphoma in a low-income country. Pediatr Blood Cancer. 2011;56:560–567.
   PubMed Web of Science ®Google Scholar
• Muller J, Csoka M, Jakab Z, Treatment of pediatric non-Hodgkin lymphoma in Hungary: 15 years experience with NHL-BFM 90 and 95 protocols. Pediatr Blood Cancer. 2008;50:633– 635.
   PubMed Web of Science ®Google Scholar
• Salzburg J, Burkhardt B, Zimmermann M, Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Münster Group Report. J Clin Oncol. 2007;25:3915–3922.
   PubMed Web of Science ®Google Scholar
• Bakshi NA, Ross CW, Finn WG, ALK-positive anaplastic large cell lymphoma with primary bone involvement in children. Am J Clin Pathol. 2006;125:57–63.
   PubMed Web of Science ®Google Scholar
• Mounasamy V, Berns S, Azouz EM, Anaplastic large cell lymphoma presenting as an epiphyseal lytic lesion—a case report with clinico-pathologic correlation. Skeletal Radiol. 2006;35:619– 623.
   PubMed Web of Science ®Google Scholar
• Kenkre VP, Stock W. Burkitt lymphoma/leukemia: improving prognosis. Clin Lymphoma Myeloma. 2009;9(Suppl 3):S231–S238.
   PubMedGoogle Scholar
• Wossmann W, Schrappe M, Meyer U, Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase. Ann Hematol. 2003;82:160–165.
   PubMed Web of Science ®Google Scholar
• Mann G, Attarbaschi A, Steiner M, Early and reliable diagnosis of non-Hodgkin lymphoma in childhood and adolescence: contribution of cytomorphology and flow cytometric immunophenotyping. Pediatr Hematol Oncol. 2006;23:167–176.
   PubMed Web of Science ®Google Scholar
• Chantada G, Casak S, Alderete D, Treatment of B-cell malignancies in children with a modified BFM-NHL 90 protocol in Argentina. Med Pediatr Oncol. 2003;41:488–490.
   PubMedGoogle Scholar
• Kent EE, Morris RA, Largent JA, Socioeconomic impacts on survival differ by race/ethnicity among adolescents and young adults with non-Hodgkin's lymphoma. J Cancer Epidemiol. 2010;2010, 10 pages, doi:10.1155/2010/824691.
   PubMedGoogle Scholar
• Pinkerton R, Wills RA, Coory MD, Fraser CJ. Survival from haematological malignancy in childhood, adolescence and young adulthood in Australia: is the age-related gap narrowing? Med J Aust. 2010;193:217–221.
   PubMed Web of Science ®Google Scholar
• Pillon M, Di Tullio MT, Garaventa A, Long-term results of the first Italian Association of Pediatric Hematology and Oncology protocol for the treatment of pediatric B-cell non-Hodgkin lymphoma (AIEOP LNH92). Cancer. 2004;101:385–394.
   PubMed Web of Science ®Google Scholar
• Pillon M, Piglione M, Garaventa A, Long-term results of AIEOP LNH-92 protocol for the treatment of pediatric lymphoblastic lymphoma: a report of the Italian Association of Pediatric Hematology and Oncology. Pediatr Blood Cancer. 2009;53:953–959.
   PubMed Web of Science ®Google Scholar